1.
Bangalee A, Hanley S, Bangalee V. MEDICINE AND THE LAW: Dolutegravir as first-line antiretroviral therapy in South Africa: Beware the one-size-fits-all approach. S Afr Med J. 2022;112(10):787-790. doi:10.7196/SAMJ.2022.v112i10.16596